Kisspeptin

Quick Facts

Property	Value
Category	GnRH Signaling Peptide
Risk Level	High
Administration	Subcutaneous Injection
Typical Frequency	1–3 Times Weekly
Estimated Half-Life	Approximately 20–30 Minutes
Primary Research Interest	Fertility / Testosterone Support / HPTA Signaling

Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and endocrine signaling compounds. Kisspeptin is a potent biologically active signaling peptide capable of altering hypothalamic-pituitary-gonadal (HPG) axis function. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

Vial Size: 10 mg
Dilutant Type: BAC Water
Amount of Dilutant Added: 3 mL
Final Concentration: 3.33 mg/mL

At this concentration:

• 100 mcg = 0.030 mL (3.0 units)

• 300 mcg = 0.090 mL (9.0 units)

2. Route of Administration

Kisspeptin is most commonly administered as a subcutaneous injectable endocrine signaling peptide.

Primary Route: SubQ Injection
Preferred Timing: Intermittent low-frequency administration
Administration Notes: Avoidance of excessive frequency is heavily emphasized in endocrine-focused discussions

3. Typical Research Protocols

Product Strength: 3.33 mg/mL
Typical Delivered Amount: 100–300 mcg, 1–3 times weekly
Frequency: 1–3 times per week
Cycle Length: 14 days maximum
Special Notes: Overdosing Hazards: Excessive dosing frequency or excessively large doses may oversaturate KISS1 receptors and contribute to receptor desensitization.
The Shutdown Effect: If significant desensitization occurs, hypothalamic GnRH signaling may decline substantially, potentially suppressing downstream testosterone and estrogen production. Because of this, intermittent low-dose schedules with built-in off periods are generally favored over continuous daily administration.

4. Summary

Kisspeptin is an endocrine signaling peptide involved in regulation of gonadotropin-releasing hormone (GnRH) secretion and overall hypothalamic-pituitary-gonadal (HPG) axis activity.

Research interest in Kisspeptin primarily centers around fertility support, reproductive endocrinology, testosterone signaling, and restoration of hypothalamic signaling pathways.

5. Mechanism of Action

Kisspeptin functions by stimulating KISS1 receptors within the hypothalamus, which subsequently promotes GnRH release.

Potential downstream effects discussed in research include:

Increased GnRH signaling
Elevated LH and FSH release
Potential increases in testosterone production
Support for reproductive hormone signaling
Potential fertility-related benefits

Because the compound operates upstream within the HPG axis, dosing frequency and receptor sensitivity are considered critically important.

6. Potential Benefits

Potential support for natural testosterone production
Possible fertility-supportive signaling
Increased LH and FSH signaling
Potential libido support
Possible restoration of suppressed hypothalamic signaling

7. Potential Risks / Side Effects

High

Receptor desensitization
Suppression of endogenous hormone production
Mood changes
Headaches
Nausea
Hormonal instability
Potential fertility disruption if misused
Limited long-term human safety data

8. Half-Life

Kisspeptin is commonly discussed as having a relatively short plasma half-life of approximately 20–30 minutes.

Despite this short duration, downstream endocrine signaling effects may persist considerably longer.

9. Storage Information

Store refrigerated before and after reconstitution
Protect from direct light exposure
Avoid repeated freeze-thaw cycles
Maintain sterile handling practices during preparation

10. Contraindications / Warnings

Pregnancy or breastfeeding
Hormone-sensitive cancers
Severe endocrine disorders
Use alongside aggressive endocrine manipulation protocols
Known hypersensitivity to peptide compounds

11. Research References

PubMed
NIH Publications
Reproductive endocrinology literature
Peer-reviewed HPG axis and fertility journals